<DOC>
	<DOC>NCT01681069</DOC>
	<brief_summary>Subjects are randomized to either IQP-VV-102 or a matching placebo. Over 12 weeks, the subjects' body weight, body fat and safety parameters are monitored</brief_summary>
	<brief_title>Efficacy and Safety of IQP-VV-102 in Weight Management</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Age 18 to 60 years 25 kg/m2 ≤ BMI ≤ 35 kg/m2 Written informed consent Known sensitivity to sources of the active ingredients and excipients Pregnancy or nursing Inability to comply with study requirements, e.g. due to language difficulties Participation in another study during the last 30 days of the screening visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>